Information Provided By:
Fly News Breaks for November 7, 2019
NVT, AME, IEX, FTV, HEPA, CSOD, ONTO
Nov 7, 2019 | 10:09 EDT
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Onto Innovation (ONTO) initiated with a Buy at Needham. 2. Cornerstone OnDemand (CSOD) initiated with an Outperform at RBC Capital. 3. Hepion Pharmaceuticals (HEPA) initiated with a Buy at Roth Capital. 4. Idex Corp. (IEX), Ametek (AME), and nVent Electric (NVT) were initiated with a Buy at Rosenblatt while Fortive (FTV) was initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
News For ONTO;CSOD;HEPA;FTV;IEX;AME;NVT From the Last 2 Days
NVT
Oct 28, 2021 | 06:55 EDT
Reports Q3 revenue $643M, consensus $603.13M. "Our Q3 results are a testament to the strong execution of our nVent team during a challenging supply chain environment. Q3 sales grew 26% as we continued to see broad-based growth across verticals and geographies. We generated strong cash flow, up more than $50M dollars year-to-date. I am grateful to our teams who are working tirelessly to meet customer commitments," said CEO Beth Wozniak. "Based on the strength in the business year-to-date and higher order trends, we are raising our full-year sales and EPS guidance. With the Electrification of Everything we are seeing strong demand for our products and solutions. The execution of our strategy on high growth verticals, new products, global expansion and strategic acquisitions is driving our growth. We are continuing to manage through supply chain challenges and delivering strong results. It is certainly an exciting time to be at nVent."
IEX
Oct 26, 2021 | 16:37 EDT
Sees Q4 revenue growth 9%-10%, consensus $692.82M.